Medical devices, healthcare technology and the business of care
PMA approval · P230005

Motiva SmoothSilk Round Ergonomix Silicone Gel-Filled Breast Implants, Motiva SmoothSilk Round Silicone Gel-Filled Breas

Motiva USA, LLC · Decision date Sep 26, 2024

MEDTECHLEDGER EXPLANATIONP230005

What did the FDA approve?

FDA approved PMA P230005 for Motiva SmoothSilk Round and SmoothSilk Round Ergonomix silicone gel-filled breast implants. The approval statement lists the indication as breast augmentation for women at least 22 years old, including primary augmentation to increase breast size and revision surgery to correct or improve the result of an original primary augmentation.

The device category is a noninflatable internal silicone gel-filled breast prosthesis under product code FTR. The applicant is Motiva USA, LLC, and the decision date is September 26, 2024. The source statement does not include safety or effectiveness findings, clinical trial data, or a supplement relationship to any earlier PMA.

FDA approval order statement

The Motiva SmoothSilk Round and SmoothSilk Round Ergonomix breast implants are indicated for breast augmentation for women of at least 22 years old. Breast augmentation includes primary breast augmentation to increase the breast size, as well as revision surgery to correct or improve the result of an original primary breast augmentation surgery (i.e., revision-augmentation).
Regulatory pathway
Original PMA
Clinical specialty
General, Plastic Surgery
Decision date
Sep 26, 2024

FDA source record · MedtechLedger’s explanation describes the recorded change.

Regulatory record facts

Identifier
P230005
Regulatory pathway
Premarket approval application
Product code
FTR
Decision code
APPR
Decision date
Sep 26, 2024
Source update
Nov 9, 2026
Original record
Open FDA source record

About this medical device

FDA device category: Prosthesis, breast, noninflatable, internal, silicone gel-filled.

Product code
FTR
FDA device class
3

The approval statement above describes the scope recorded for this original decision. Later supplements may change the device or its indications.

FDA decision timeline

  1. P230005 received

    Application receipt date recorded by FDA.

  2. P230005 · FDA decision

    APPR

  3. P230005/S005 · Related supplement

    Motiva SmoothSilk Round and Round Ergonomix Silicone Gel-Filled Breast Implants

  4. P230005/S002 · Related supplement

    Motiva SmoothSilk Round Ergonomix Silicone Gel-Filled Breast Implants, Motiva SmoothSilk Round Silicone Gel-Filled Breas

Timeline entries are records held by MedtechLedger for P230005. View FDA’s full supplement list.

Related devices and submissions

Same PMA: P230005

Explore the linked device profile

Other records with product code FTR

Product / regulatory recordCompanyPathwayDecision dateSource
Tiger Aesthetics Medical, LLCPMA supplementNov 4, 2026FDA
Mentor Corp.PMA supplementOct 23, 2026FDA
Mentor Worldwide, LLCPMA supplementOct 23, 2026FDA
AllerganPMA supplementSep 29, 2026FDA
Mentor Worldwide, LLCPMA approvalJun 14, 2013FDA

A shared product code identifies a classification relationship; it does not establish clinical equivalence.

Regulatory context

An original PMA is a premarket approval application. The recorded approval scope is described in FDA’s order and supporting documents.

Read our guide to FDA clearance and approval · FDA’s explanation of this pathway

Manufacturer intelligence

Motiva USA, LLC

Headquarters
Not reported
Brand website
Not reported
FDA applicant address
2543 Mesa School Ln., Santa Barbara, CA, 93109

Sources and methodology

FDA fields and approval-order wording are presented as source information. MedtechLedger explanations are identified separately and describe the scope of the recorded decision. Indications from an original PMA are historical unless confirmed against subsequent labeling and supplements.

How we use FDA records